A Special Situation 50 Years
in the Making:
3 powerful forces have converged on this one moment in time, giving you the real chance at massive wealth creation.
The last time this happened, investors had the chance to make 21 times their money…
Hi, my name is Amber Lee Mason, Managing Director at Bonner & Partners.
Recently, I spoke to one of the biggest technology experts in the world, and uncovered something remarkable…
Take a look here:
This is a chart of Kite Pharma (KITE). See here—the stock jumped as much as 295% in 5 months.
This is Penumbra, Inc (PEN)—another tiny company. Up more than 2,000% in 32 days.
CyberArk Software—4,261% in 4 months:
And there are more than a dozen other cases just like these:
If you’d put $1,000 into each of these companies, you’d be sitting on $355,700 right now.
With that kind of money you could pay off a house…
Buy a cabin and 20 acres in the Smoky Mountains…
Send your grandkids to Harvard.
Or let it compound and pay you in retirement.
What you just saw are just a few examples of what could be waiting for you in the next 18 months:
Spectacular gains from a subset of the market that is almost guaranteed to move—thanks to 3 key factors that are merging together for the first time in 50 years.
What’s happening here?
This has nothing to do with earnings calls, drug approvals, or anything you’ve likely heard of.
There is a much bigger force at play, 50 years in the making, finally converging, potentially forcing dozens of stocks into the stratosphere…
This is—hands down—the single biggest speculation we’ve uncovered in the history of our business.
So don’t put off watching this video. Because I’ve never seen anything like it in a decade of trading and investing.
Let me explain…
It all started with a surprise from Tokyo…
Four months ago, an American aerospace engineer, active angel investor and high-tech corporate insider paid us a visit from Tokyo, Japan.
That’s where he’s been based for 16 years.
Japan is the mecca of the world’s high-tech scene. Steve Jobs used to spend a lot of time in Tokyo and Kyoto. And it’s no wonder: the Japanese worship technology. What they have access to over there is sometimes 3-6 years ahead of any technology you’ll see in the States.
For example, Japan had cell phones small enough to hide in your hand as early as 1998—at least 6 years before they appeared in the States.
And they had touchless payment systems throughout their public transportation systems in the early 2000s. We’re just rolling that out now with platforms like Apple Pay.
My contact from Japan traveled here to hand me a document detailing a special situation 50 years in the making.
He believes as many as 116 venture capital firms have likely seen some of the contents of this powerful document. But it hasn’t been discussed or been made public—yet.
I didn’t know what to make of it at first. So I spent several hours with this gentleman.
This document is a blueprint on how to make a fortune from a niche market of tech companies over the next 18 months…
And here’s what’s even more fascinating….
A new change in government law has created a catalyst for this opportunity.
A change that—on the surface—appears to be just another Washington boondoggle. But which will actually help many investors reap record profits over the next 2-3 years.
I’ll explain everything in today’s letter… and show you what this gentleman showed me…
Including how to make up to 10 to 20 times your money, if you make a few careful moves that we’ll share today.
And why, if everything goes perfect, early investors in this situation could make 50 to 100-times their money over time.
Sounds hard to believe. You should be skeptical. (I know I was.) But stick with me and I’ll share his findings…
Because what he’s uncovered is the secret that can lead to actual gains like…
But please, keep in mind… this is a temporary situation—an unbalancing in the markets.
Once it’s gone, it’s gone for good. Don’t wait on this and think you’ll get in later. You’ll likely miss out altogether.
The truth is, it may take another 50 years to see another opportunity like this.
So please pay close attention.
The Window Won’t Stay Open for Long
According to my contact, 3 major economic forces are responsible for this situation.
3 powerful forces that are coming together at this exact moment… and will reshape our daily lives….
I don't have a ton of time here to go into details. But it's important you know the broad strokes.
The first force is what my insider calls “exponential change.”
It’s a very powerful force, but one most investors don’t truly understand.
Let me show you a simple example…
Take this penny here…
Imagine if it doubled every day for 30 days.
How much do you think it would be worth?
At first, not much happens.
By day ten, you’d only have $5.12.
But by day 28, you’d be sitting on $1.34 million.
And by day 30, you’d have $5.39 million.
This is what we call “exponential growth.”
Something similar has happened over the last 50 years in technology.
You’ve probably heard of it:
Named after Gordon Moore, a co-founder of Intel, this law states that the number of transistors on a computer chip will double every 18 months.
In the 70s and 80s, computing power advanced much like the penny from our example…
The gains seemed small at first.
But computing power is experiencing incredible growth now…
And as a result, we’re about to see stunning advancements in technology that will dwarf those made in previous decades.
As I’ll soon show you, what’s ahead of us will be even more spectacular.
So that’s the first “force”: technologies are advancing at exponential rates. And this is happening right now, today.
And it’s colliding with a second force you should know about. This “collision” is setting up a one in 50 years play to make a fortune…
At the same time that technology is experiencing “exponential growth”… the costs of many of these advanced technologies are plummeting...
For example, in 1996, the $55 million ASCI Red Supercomputer was the first computer to reach the speed of 1 Teraflop.
It occupied a warehouse nearly the size of a tennis court.
In 2014, Sony released its PlayStation 4 video game console.
It has almost twice the computational power as ASCI Red… and it costs 100,000 times less. Just $400. And it could fit in a small backpack.
That change occurred in just 20 years.
This single example shows you that…
Our computers are getting much faster, much smaller, and much cheaper.
This combination of exponential technologies that are exponentially cheaper… has created the perfect environment for innovation.
And it’s also why we’ve seen such radical changes in the stock market too…
It used to take a typical Fortune 500 company almost 20 years to be worth $1 billion in the stock market.
Compare that to Facebook, which only took 6 years.
Or Uber, which only took 4 years.
My point is, as technology improves exponentially…
And as costs continue to plummet…
Certain companies are growing much faster than normal…
And savvy investors who understand the powerful implications of exponential change can get rich must faster too.
But there’s one more force at play here… it’s the key to this entire opportunity.
Let me explain…
An Unusual Circumstance in the Stock Market
So far I’ve told you about two major forces…
1) The exponential advance of technology
And 2) how the cost is constantly plummeting
Right now, they’re converging with a third force…
And combined, they’re giving rise to an opportunity to make extraordinary amounts of money.
The types of gains that early investors saw in…
This third force has to do with a systemic change in the way technology companies are financed and go public on the stock market.
As a result of this change, there is an enormous backlog of private companies ready to go public, or make their initial public offering (“IPO”).
It’s almost the financial equivalent of water behind the Hoover Dam.
Right now, that dam is beginning to crack… and over the next 12-18 months, you’re going to see a flood of amazing opportunities to make 10, 20… even in some cases 50 to 100 times your money (over time).
I’m talking about a next generation of business like Qualcomm, which has multiplied 105-times in value…
Turning every $5,000 into $526,000…
Medivation, which has returned $126,000 for every initial $5,000.
Incyte, which has multiplied early stakes by more than 40-times over…
Turning every $5,000 into $200,000.
And EMC Corp, which has returned $1.5 million for every $5,000 invested early on.
There are a handful of factors causing this backlog of IPOs. But the most important reason this is happening is because:
Companies used to “go public” on the stock market because they needed cash to get their business off the ground.
By making shares of their business available to the general public, they could get a lot of new capital right away and launch their start up.
I say “used to,” because that’s no longer the case…
As I mentioned, the cost of everything related to technology has fallen drastically. So new companies don't need as much capital as they used to get started.
Just 15 years ago, they might have required $20 million. Today, you can start a new tech company with just five grand. Simply put, because growing a company is so much cheaper, there’s no rush to go public when you’re just starting out.
Plus, any initial money a new start up needs…
Banks, hedge funds, and other institutions are more than happy to provide.
In short, technology and biotech companies have been taking their time and making sure their businesses are solid before going public on the stock market.
And now, dozens and dozens of small but mature, cutting-edge companies are ready to list their shares on the stock market at practically the same time.
As Fortune wrote just a couple months ago:
“A tremendous backlog of potential
technology IPOs is building up….”
Of course, some of these companies will fail…
But some will absolutely change the world…
And either get gobbled up by the Facebooks, Microsofts, and Apples of this generation… or become giants in their own right.
One of the perfect examples of this scenario is LinkedIn, a social media site for aspiring job hunters and recruiters.
The company doubled the day it went public… soared as much as 333% over a 22-month period… and just weeks ago was acquired by Microsoft for more than $26 Billion.
This gave early investors 3 separate opportunities to make money…
In our interview series, we told you about two opportunities that might turn out the same once they go public…
Slack and Coinbase.
Slack is a business software company whose growth has been viral. In roughly 2 years, the number of people using the company’s software has jumped from 16,000 to 2.7 million. And that’s with hardly any advertising.
The company has over 90,000 companies using its software, including NASA, Salesforce.com, eBay, HBO, and Intuit.
And Coinbase—the second business we revealed—hosts the world’s first licensed Bitcoin exchange. It’s a legal exchange where people can buy and sell digital currencies.
Some of the biggest players in the Venture Capital space are backing it…
Like Andreessen Horowitz, which was an early investor of Skype and Facebook.
If you think digital currencies are here to stay, then Coinbase will be a great speculation. The company collects a .25% fee on every bitcoin transaction.
And according to Infiniti Research, the alternative currency market should grow between 150-200% over the next 4 years.
We expect these businesses to go public soon… and when they do, early investors stand to make a fortune.
Much like they did with Neogenomics, which has returned “day one” investors more than 14-times their money.
And Tyler Technologies, which has multiplied the stakes of its earliest investors by 109-times… turning every $5,000 into $549,000.
Coinbase and Slack make up a list of companies we call the “Venture Elite.”
It’s a 21-name list of the most promising, venture-backed companies that will likely go public over the next 12-18 months.
Remember, when you pick the best opportunities, there are three ways to make huge potential gains with these businesses…
1) You can make a fortune right after the company IPOs…
Like Global Blood Therapeutics (GBT) and Aduro Biotech (ADRO), which jumped 130% and 123% on the first day of trading on the stock market.
2) You can make even more money as the business continues to grow after the IPO…
Like Adobe Systems, which has handed early backers an astonishing $440,000 for every $1,000 investment.
3) And you can very often cash out with an even bigger payday when the company gets bought out by the behemoths in the industry.
For example, when Abbott Labs agreed to buy out Advanced Medical Optics… shareholders made an extra 218% in just one week!
Now don’t get me wrong, nothing in the market is guaranteed. But the potential in these IPO’s are staggering. The companies we’re tracking today are the future Adobe’s and Advanced Medical Optics of America.
Future 10, 20… even 100-baggers that are right on the cusp of going public on the stock market.
Several years from now, after you’ve added a couple zeroes to your initial stake, you’ll remember this letter and recall this special list.
Already, one of the names from this list went public this year. It’s risen as much as 175% in a month.
In a moment I’ll also reveal one more company from this list to look out for…
This company has the real potential to turn a $10,000 stake into $100,000—or more.
First, it’s important to understand what really sets this list apart…
You see, my contact in Tokyo is one of the best in the world at scouting out these sorts of tiny, up and coming technology plays.
His name is Jeff Brown.
For the past two decades, Jeff has been at the center of the world’s technology scene… as an engineer, a turnaround specialist and an active angel investor.
He was the head of Global Strategy of a division at Qualcomm—the wireless semiconductor giant—in 2005.
After joining the company, shares more than doubled.
Of course, many factors go into a stock’s success…
But Jeff has a knack for finding companies with solid potential. Even if no one else sees it at the time.
For example, back in 2008 a global semiconductor company called NXP Semiconductors recruited Jeff to join their executive turnaround team by taking over its Japanese subsidiary. The company was struggling and needed some emergency help.
Within two years the business was back on track. And after going public, the stock has risen as much as 761%. (And Jeff’s personal stake in the business rose 940%.)
In all my time in this space, I’ve never met anymore more plugged in or knowledgeable about tech than Jeff.
About 5 years ago, Jeff began applying his knowledge to the private technology market.
He began investing in promising start-ups… and talking to their CEOs and founders…
As Jeff told me, this type of private access is absolutely vital to his success as a research analyst and venture capitalist:
So you get these perspectives from the eyes on the ground who are operating in this space, thinking about new business models and it's absolutely invaluable information. And because I'm writing a check, it gives me a different kind of access than if I were a journalist, just as a journalist. They're not going to spend time with me, why, because they've got a business to create. If I'm writing a check, I own part of the company. They're going to answer my calls, they're going to respond to my e-mails, they're going to meet with me.
He went on to tell us this type of deep, private research is what separates what he does from the “gamblers” out there:
You've got to do some research on the industry, you've got to obviously understand the company, you need to speak with at least one of the founders, you know, see if you believe in their ability to execute, if they can clearly communicate what the mission of the company, how the tech is differentiated, what makes them special. You know, just – otherwise you're just gambling, right. So I'd rather speculate instead of gamble.
In 2012 Jeff began investing heavily in these private tech and biotech deals.
So far, he owns stakes in 44 private companies.
All 44 of Jeff’s companies are active, operating businesses today. If you know anything about this space, you know how unusual that is. Typically, these deals take 3-5 years to play out. And with early stage companies, almost 99 out of 100 fail.
But, as I’ve shown you, Jeff has an information edge and an approach to research that most investors—even many professionals—don’t have.
And it was through his personal research that Jeff became familiar with the situation I’ve been telling you about—this incredible backlog of later stage private companies ready to go public.
You see, most people don’t have the time, money, or patience to invest in early stage businesses. It takes a lot of capital to even qualify for these deals.
But IPOs are a different story. All you need to invest in them is a brokerage account… and enough money to buy shares.
Instead of waiting 5 years, the gains can be lightning fast…
But hundreds of companies go public every year. There’s little to no information on these businesses worth looking at online.
How do you know which companies are worth putting some money into?
That’s where Jeff comes in….
"Jeff Brown is one of the brightest and most capable individuals I know. If you like to speculate on technology, you should absolutely read his work."
Jeff talks to the CEOs… the medical officers… and the engineers. Unlike some “basement Internet analysts,” he knows the technology…
He studied aerospace engineering at Purdue… and has done real technical work on massive projects for some of the world’s largest companies like Qualcomm, Juniper Networks and NXP Semiconductors. This knowledge is crucial to understanding whether a tech company is worth buying or discarding.
It’s how Jeff has able to make sense of all of the academic journals… which, in many cases, hold the secret to identifying technology breakthroughs long before they ever go public.
It’s also why many of Asia’s biggest TV shows have had Jeff on as a guest. He’s able to take a dense technology idea and make it easy to understand…
And he has a knack for reaping landfall gains… Like the 743% gain that happened in just 3 days from a company he invested in called Infospace…
And it’s because of Jeff’s deep understanding and connections… that he hears about big tech and biotech breakthroughs before they ever appear in the news.
Which brings me back to the list I mentioned earlier.
It’s called the “VENTURE ELITE.”
It’s a handpicked list of 21 companies Jeff believes are likely to go public within the next 12-18 months.
In the hands of an amateur, this idea could be dangerous. Not every IPO does well. You can’t just fiddle around on the Internet and compile a list.
Jeff has amassed a flawless personal track record and removes much of the guesswork by evaluating a handful of key factors:
And of course, he talks to the key players involved.
In fact, he just returned to Tokyo from a trip to New York, where he spent time with the Chief Medical Officer of a private startup specializing in mapping the human genome.
“It’s a future member of the Venture Elite,” Jeff told me.
As a result of this specialized legwork and analysis, he has created the type of list wealthy investors typically pay $10,000 to $20,000 a year for.
It’s a hotlist of the 21 companies he suspects will go public over the next 18 months.
And I want to give you access to this list today.
When you have it, you will possess an incredibly valuable blueprint for potentially making huge gains in the market.
Let me show you what I mean…
So, why should you get your hands on this list right away?
Just a few months ago, one of Jeff’s Venture Elite businesses went public.
The Bill Gates-backed company is called Editas Medicine. They developed a revolutionary “gene-editing” technology that lets them “cut out” bad genes.
The implications of this breakthrough are astounding. We now have the potential to cure more than 6,000 genetic-based illnesses:
In the years ahead, this breakthrough will continue to achieve results mankind has long considered impossible.
Keep an eye on the news. You’ll see this company and its technology in those little 30-second clips that appear on the nightly news about “a major update in the fight against cancer”… or Alzheimers… or Parkinson’s.
The market has responded. In just a month, the stock rose as much as 175%.
Jeff believes it will still rise another 1,000% from here—if a larger competitor doesn't buy it out first.
Remember, there are 3 ways to make extraordinary gains on these Venture Elite stocks.
So far, readers of Jeff’s research have had a chance at huge gains immediately after Editas Medicine’s IPO.
175% is Just the Beginning…
What’s most amazing is, Editas is just the beginning…
Two more of Jeff’s Venture Elite companies also IPO’d this year, handing savvy readers the chance at big gains…
Intellia, another breakthrough biotech company, soared as high as 38% in just 25 days!
Then, communications company Twilio, shot up a staggering 90% the day it hit the market!
So you see why it can be so profitable (and exciting) if you’re able to buy these little dynamos on “day one”...
But remember, though you may have missed your chance with these three companies, there are many more Venture Elite companies yet to go public…
Each with the potential to hand you a 1,000% gain or more!
Before I tell you more about one of these companies…
And show you how to claim access to the full list today…
There’s one more vital piece of information you should know.
A “twist,” if you will…
Little-Known Federal Clause #106 Creates “Dark Pipeline”
How does Jeff know these private businesses are going public?
Well, 4 years ago, it was easier to uncover this information. You’d see news of it months in advance.
Now, it’s difficult. And most folks don’t have much time at all to prepare.
Let me explain…
In 2012, Obama signed the JOBS act into law. You may have heard of it. The purpose of the law was to give a “boost” to America’s small businesses.
Well, Congress snuck an odd clause in section 106 of the law, under the vague heading “other matters”…
Essentially, the clause allows private companies to go public in secrecy.
Until they passed that law… a company that wanted to list its shares on the stock market had to apply months in advance. And they had to basically make their intention very public.
In short, prior to the JOBS Act, everyone knew when a company was going public way ahead of time.
In that old system, investors would have months to research the company… to see if it was worth their time and money.
Now everything has changed.
A company can apply for an IPO with the Federal Government… and no one knows about it. Not even many of the “pros.”
Some call this the “Secret IPO.” Or the “Dark Pipeline.”
According to the Wall Street Journal… about 850 companies so far have elected to go public this way—secretly.
When a company goes public this way… the only time you and I hear about it is when they file a form with the U.S. Government called the “S-1/A.”
This form doesn’t tell you exactly when a business is going public. Only that they’re working towards an IPO.
This route saves the company a lot of time and money.
They don’t have to field calls from reporters…. or jump through many of the other hoops companies used to jump through.
Once they fill out this form, you have anywhere from one month… to as little as a few days to investigate the business… and do all of your due diligence.
That’s bad news for most investors…
But good for you…
Because access to Jeff’s Venture Elite Hotlist gives you the inside scoop on these companies months in advance of their potential IPO.
Consider Editas Medicine, the company on Jeff’s “list” that jumped as much as 175% in roughly a 1-month period.
Editas opted to file for a “secret IPO”—like most companies do these days.
On January 4th, 2016, they filed their S-1/A form.
And on February 3rd, the company went public.
Our firm, Bonner & Partners, subscribes to a comprehensive database of over 1,100 newspapers, academic journals, and magazines.
Over that 1-month period—from the time Editas filed to the day before they actually went public on the stock market...
We found only 26 mentions of Editas Medicine in our database.
26 articles in the world that talked about this revolutionary new business.
So, if you were lucky enough to read one of those 26 articles about Editas, you only had a month or less to vet the business.
Compare that to Salesforce.com. They went public on June 1, 2004—prior to the JOBS Act.
They filed their papers 6 months earlier—on December 18, 2003.
Over that 6-month period…
Our database shows that the media wrote about them 147 separate times—6-times as much as Editas.
Had you bought shares when Salesforce.com went public, you would have had the opportunity to double your money in the first 6 months…
And make 21-times your money had you bought early and held on.
With 6 months of lead time…
Investors could have found out about Salesforce.com… dug into their business… and participated in those early gains.
But that has changed…
This new law has taken away a big advantage from regular investors.
Like I said, bad news for everyone else.
But great news for you…
Because you’ll be among the small group of investors on the “inside” of this trend… thanks to Jeff Brown and his unique system for spotting these deals and alerting folks to them.
Let me quickly walk you through Jeff’s process…
The first thing you should know is that Jeff begins digging into Venture Elite companies years in advance.
For example, the companies he’s investigating today are the businesses that will go public in 2018 and 2019. That’s how far ahead Jeff is planning.
For example, in the case of Editas Medicine…
Jeff was following the company’s gene editing breakthrough almost one year before the business formed.
He was following its development in late 2012—when it was just a small group of bright minds assembled in one lab.
Later, when he learned all of these key scientists split up and went their separate ways, he tracked where they ended up.
One of the businesses was Editas. Another is on Jeff’s Venture Elite list.
My point is, Jeff is constantly monitoring the technology community… and often knows about companies before they even form… based on their work that appears in technical journals.
In the second step, Jeff aims to narrow down the companies he’s tracking to see if they have what it takes to make “the list.”
To do this, Jeff carefully monitors the company’s private financing.
Because certain venture capital firms have the cash and clout to support and even fast track a young company.
With Editas, Jeff began tracking the business in late 2013. That’s when it began its SERIES A round of raising capital. Some very credible names invested in Editas, including:
So this “smart money” move was a clear-cut indication to Jeff that Editas has huge potential…
In the THIRD STEP…
Jeff constantly monitors the company until it releases its S1/A form. This indicates the company could go public in as little as 3 weeks.
By this point, Jeff has done all of his due diligence. He knows he wants to recommend the company. He’s just waiting for the precise date it’ll be available on the stock market.
For example, by the time Editas filed its S1/A, Jeff had been following it for more than 3 years!
Jeff has a unique way of scanning the Government files for these forms. The moment it’s filed, Jeff knows about it… and that’s when he sends out an urgent alert to subscribers.
So that’s it—3 simple, straightforward steps. And all you need to know is that when you get an alert from Jeff… make sure you act on it right away…
Some of these plays may take a couple months to pop.
But others jump right away—and if you drag your feet, you may miss out on a lot of money.
Remember, there are three ways to make a ton of money from the best of these newly public companies.
First, when they first go public…
For example, Dicerna Pharmaceuticals went public in 2014. Its stock price shot up 206% in 24 hours.
Next, as the stock begins to gather steam and make a longer run.
Stryker Corporation, for example, has risen 133-times in value since its IPO—and is still climbing.
And Biomet jumped as much as 30,000% in value.
Finally, sometimes bigger companies acquire these stocks… giving you a nice little “pop” at the end.
For example, a company called Altera climbed as much as 2,193% after going public. Last year, when news broke that rival chipmaker Intel was buying the company… shares “popped” an additional 56%. A nice cherry on top.
These are the types of companies Jeff is shooting for in his Venture Elite list.
Let me tell you about another company on his list that you should pay close attention to.
Jeff believes this company will be
a 10-bagger once it goes public…
What if you had a second chance to get in on a company like Tesla Motors…
Would you take it?
Since its IPO in 2012, Tesla’s stock has risen 1,052%.
Had you invested $10,000 early on, you’d be sitting on more than a million bucks today—in just 4 years.
Elon Musk, the founder and owner of Tesla (and also a co-founder of PayPal) is a mega-billionaire. And a serial inventor too.
3 years ago, Musk made public a 57-page white paper on an invention he believes could revolutionize public transportation.
What is this project?
Have you seen those pneumatic tubes at your local bank or pharmacy?
You take out the canister, put it in the tube… and whoosh… it shoots through, hurtling toward its destination…
Hospitals have them too….
They deliver drugs and specimens from nurse’s stations to labs.
These tubes essentially use pressurized air to produce mechanical motion.
Musk believed he could take the same physics behind pneumatics… and apply it to transportation.
He floated the idea of a vacuum-tube transportation system that could take passengers from LA to San Francisco at 760 miles per hour—the speed of sound—in just 35 minutes.
Or imagine traveling from Baltimore to DC in just 4 minutes.
At first, everyone except Musk’s devotees laughed at the “vacuum train” idea.
But then some really credible groups began backing it.
MIT created a 30-person team to build their own vacuum train.
115 academic research centers around the world quickly followed suit. (This summer, 30 of them are pitting their prototypes against one another in a 1-mile race.)
There are a couple American startups hard at work on prototypes of their own…
But there’s only ONE business working on this technology that Jeff believes you should put some money into.
They’ve already received over $92 million in funding so far…
One of their big investors is the French national rail company SNCF. So even the “old guard” of rail transportation is backing this idea.
Another key member of the company is an investor whose early stake in Uber has risen 14,382% and made him 500 million bucks.
What about the technology itself?
This May, the company conducted a very powerful, public demonstration in the Northern Nevada desert. It was only a test module and a short track. But the test was a perfect success.
Rick Stella, one of the many technology journalists in attendance, later wrote:
“We traveled to Las Vegas with a pocketful of doubts, and giddily left our jaws on the floor after witnessing a truly disruptive technology.”
The next stage, according to Jeff, is for the company to go public. To build out the design… lay down track… and deal with city and state governments, they’ll need a lot more money.
When they do go public, you will be the very first to know. And of course, you’ll learn the name of this business as soon as you access our Venture Elite hotlist.
The moment Jeff’s alert system is triggered, he will send out an urgent email to subscribers… letting them know that an IPO is coming… what the right price is to pay… and other important details.
Now, this business has all the potential in the world to return early investors 10 or even 20 times their money…
I mentioned Tesla, another Musk project that’s done just that. Every $10,000 invested when Tesla went public is worth as much as $105,000 today.
And his other public project—SolarCity—jumped 562% in little over a year.
But there’s something you should keep in mind…
It’s something every subscriber reading this letter absolutely needs to know.
These Venture Elite plays are NOT meant for your rent or grocery money.
If you’re living on fixed income and counting pennies, this is NOT for you.
If you are just starting out as an investor, same thing--these Venture Elite plays are NOT for you.
Companies like the Elon Musk-inspired business I just described and the others I’ve mentioned could certainly return 10 to 20 times your money….
And even 100 times your money or more—over time.
But some of these businesses will fail. In fact, the laws of the markets dictate that some absolutely will.
Having Jeff Brown on our team, whose experience has allowed him to defy those laws… and stack the odds in your favor, is the ONLY reason we’re sharing this information with you today.
I promise you—there’s no one in this business more qualified than Jeff Brown to do this type of research. He is a true insider in this world… and one of the very few who understand the technology and how these deals are financed.
So even if you don’t follow Jeff’s recommendations, his research will give you a valuable insight into how the future will affect your life…
Remember, Jeff has invested in 44 private deals of his own. And all 44 are still in play. This is freakishly unnatural—even among the very best investors in Silicon Valley.
But despite having Jeff on your side… and his unusually good track record of spotting these opportunities…
If you’re looking to invest money, you should not pour all of your money into any one of these plays.
But that’s okay, because a small stake is all it takes for the chance at a massive fortune when you invest in exponential technology…
For example, one of Jeff’s favorite companies is a virtual reality business that has the venture capital world buzzing.
I mentioned this business to a colleague of mine, who worked at a venture capital law firm in this area for over 7 years.
He has brokered hundreds of deals and seen many of the biggest technology breakthroughs to hit the market. "They have tons of cash,” he told me. And said that, based on how much has been invested and the people who are investing, their tech seems like it’s going to “change the world."
Typically, a firm like this one will ship its new, cutting edge product to China to be manufactured. It's cheaper and more efficient.
But they've decided to do everything in-house, in a location in Florida.
Jeff tells us it's because what they have is so revolutionary, they are worried the Chinese or one of their competitors will steal it if it ever leaves their facility.
Now, this is one of the Venture Elite companies Jeff believes will do much better than all of the others.
He told me, over time, this company
has the potential to multiply in size 100-fold.
“It could be the next Apple,” he said.
It’s easy to imagine a $5,000 stake growing 100-fold and what that would look like in your account…
If you feel like you have the temperament and experience to approach this idea the right way…
Then I want you to have access to this list today…
We’ll give you instant access to the
Venture Elite Hotlist: 21 Exponential Technology Companies That Could IPO In The Next 18-24 Months…
All you have to do is take a trial subscription to Jeff Brown’s new research advisory, Exponential Tech Investor.
You’ll learn everything you need to know about this special situation, including the full list of 21 companies that could go public any day.
I say 21 companies, but that could easily change in the short week between writing this letter you reading it.
You see, Jeff believes a half dozen of these companies could go public in 2016 alone.
Plus, Jeff is constantly adding to and updating this hotlist.
Let me tell you about one more company on the list that we’re really excited about…
One device in particular, which looks like the world’s smallest cell phone, has captured Jeff’s attention.
It’s made by a tiny company on Jeff’s list…
And has captured the attention of the global medical community as well.
This single device can tell you the identity and makeup of a disease or pathogen within hours.
Imagine, if every doctor in every hospital, and every guard at every security checkpoint around the world could diagnose disease and deadly viruses with a device the size of a flash drive?
That’s the plan of the startup Jeff has been tracking. And they’ve already made a name for themselves. Their tiny device was responsible for sequencing the deadly Ebola breakout that terrorized millions a couple years ago.
And the device is now in the jungles of Brazil—“ground zero” for the Zika virus, which you’ve probably heard about on the news.
NASA has been taking this device on missions as well. If someone gets sick in space, there aren’t doctors to diagnose or hospital labs on the shuttle.
The company has raised $379 million to date… and has the potential to follow the path of other successful bioinformatics companies…
Like Illumina, which is also in the business of genetic sequencing. Since going public, the company’s stock has risen as much as 1,494%.
Could the shares of the company Jeff’s tracking do as well?
Once this business goes public…
Jeff believes its stock could easily jump 10-20 times in value over the next few years.
Turning every $10,000 into $200,000 (or more).
When you take a trial subscription to Exponential Tech Investor, we’ll place your name on a VIP distribution list. You’ll hear from Jeff as soon as he hears this business—and any others—go public.
You'll know everything that Jeff knows about these situations. And you'll know exactly when it's time to make these trades... because Jeff will alert you immediately via email.
$1,000 into $355,700
By becoming a subscriber to Exponential Tech Investor, you'll be one of a relative handful of folks that have access to Jeff's Venture Elite list...
As I mentioned at the start of this presentation…
If you’d been following these types of IPOs over the past 5 years…
Like Penumbra, Kite Pharma, and the others I’ve mentioned:
You could be sitting on $355,700 right now, had you put $1,000 into each of them.
Or $1,067,100 if you’d invested $3,000 into each of them.
Could Jeff’s Venture Elite list do as well?
We believe it has the potential. That’s why we’re sharing this letter with you today.
Looking back, how much would you pay for that kind of information? How much would you pay to have $355,000 today?
I've seen tech and biotech services offered by other investment groups that cost $500 or $399… even as low as $99.
You'll find hundreds of these types of services on the Internet and in your inbox. Just like you'll find hundreds of gamblers in a casino.
But the fact is, you're not going to find any other technology investing research advisory headed up by someone like Jeff Brown.
Jeff is a tech expert. He’s the guy the biggest corporations in the world—like Qualcomm and NXP—have turned to when they’ve had billions of dollars on the line.
He’s built start ups.
He has a flawless record in his own angel investing….
And he’s spent more airtime than anyone I’ve ever met doing boots-on-the-ground research. (Jeff tells me, he slept in hotels and on airplanes for over 250 nights of the year…for three straight years.)
I won’t get into the details, but we had to pay a lot of money to retain Jeff and make his research exclusive to Bonner & Partners.
One year of Exponential Tech Investor costs $2,000.
If that seems costly, that's because it is. We believe our new research is worth every penny (and probably a whole lot more).
If you cannot comfortably afford to pay for our research, that’s OK. I hope you’ve learned something from reading this video.
I’ve only seen one other service in the world covering the types of business on Jeff’s Venture Elite list. It costs $19,200 a year. And Jeff subscribes to it. As he says—they just provide data on the venture space. They don’t provide analysis and recommendations.
Would you pay $2,000 for the opportunity to make $130,000… or $350,000?
Let me show you what you’ll receive as a new subscriber to Exponential Tech Investor.
What You'll Get as a New Member
Within 15 minutes of subscribing to Exponential Tech Investor, you’ll get your password to the Exponential Tech Investor website… and access to:
You’ll also receive:
Of course, all you’ll really need to do is follow your email and look out for alerts from Jeff.
He’ll tell you everything you need to know—what to buy. When. And for how much. Plus, unlike many other services, which only recommend when to buy and then forget about the subscriber…
Jeff will tell you precisely when and how to exit your positions as well.
In addition to these reports, your $2,000 includes 12 monthly reports from Jeff, in which he recommends the best trades in the market.
Some of these will be “Venture Elite” recommendations. Others will be early stage technology companies that have already gone public.
You'll also have an instant lifeline from Jeff - he'll immediately email you as soon as it's time to buy one of these Venture Elite companies. It's up to you at that point to take action.
Before I tell you about the special perk we’re offering for a limited time….
Let me tell you about one more bonus you’ll get through this offer.
Exclusive Gathering in the Pacific
Once a year, our Family Office members gather at Bill Bonner’s development in Rancho Santana—a luxury development in Nicaragua overlooking the Pacific Ocean.
These are folks who have paid $10,000 to receive all of the Bonner family’s research for life.
Jeff Brown was one of our guest speakers this year.
Before the gathering, we asked him, “If you could put your money into just one publicly traded company right now and hold it for the next few years, what would that be?”
Jeff unveiled his answer to this small group of wealthy investors. As he said, it’s a tiny company with a device that “sits at the crossroads of artificial intelligence, self-driving cars, and virtual reality.”
The company has licensing contracts with many of the world’s biggest tech giants—like Samsung and Intel.
Jeff believes its share price could rise 500% or more over the next 5 years.
You’ll get the full presentation Jeff created for this event, when you take a trial subscription to Exponential Tech Investor.
Before I tell you how to subscribe, let me give you one more reason to subscribe to Jeff’s Exponential Tech Investor today…
As an independent financial publisher, the success of our business depends on how satisfied you are with our research.
If you like our work and think our investing strategy is right for you, then you stick with us and Bonner & Partners continues growing as a business.
Sign up today – claim your membership for the limited time we're offering it.
You'll have 30 DAYS to decide whether our research is right for you.
If for whatever reason you want to cancel your subscription in the first thirty days, just let us know.
We'll give you 100% of your money back.
Plus, you can keep all of the bonus reports we send you. They’re yours to keep, no matter what.
But it gets even better…
The list you’ll have access to today represents the culmination of years of Jeff’s finest work.
And that’s why we're offering an unprecedented guarantee:
We guarantee that at least 12 of Jeff’s companies will go public over the next 18 months. If for some reason they don’t, just contact us and we’ll add an extra year of membership for free.
If you’re ready to claim access to Jeff’s list right now… and set yourself up to potentially make 10-20 times your money over the next couple years…
Then make sure you click the button below and enter your information on the membership page on the next screen.
Thanks for reading today…
Amber Lee Mason
Managing Director, Bonner & Partners
P.S. Oh… one more thing…
Last night (well, it was morning for him in Tokyo), Jeff described a new opportunity he’s looking into. It’s a backdoor way to own shares of some of these private companies before they hit the public stock market. Just think about owning companies like Google and PayPal before they went public.
Jeff is going to investigate further. If this “backdoor” is as safe and lucrative and he suspects it is… expect a special report from him soon.
So make sure you hit the button below—and get started today.